Philip Toltzis, MD
Philip Toltzis, MD, is a critical care specialist in the Division of Pediatric Pharmacology and Critical Care at University Hospitals Rainbow Babies & Children’s Hospital He also is Professor, Pediatrics, Case Western Reserve University School of Medicine. He is the former Medical Director of the Pediatric Intensive Care Units at UH Rainbow Babies & Children’s Hospital and at Hadassah Hospital, Jerusalem, Israel.
Dr. Toltzis is board certified in pediatrics, infectious diseases and critical care medicine. His special interest is in hospital acquired infections and other infectious diseases. He has been a member of the UH Rainbow Babies & Children’s Hospital medical staff since 1988.
Dr. Toltzis is a graduate of the University of Pennsylvania School of Medicine, Philadelphia, Pa. He completed a residency in pediatrics at UH Rainbow Babies & Children’s Hospital and was Chief Resident in his final year of training. He served a clinical and research fellowship in infectious diseases at Children's Hospital and Harvard Medical School, Boston, Mass., and a combined clinical and research fellowship in the Division of Pharmacology and Critical Care at UH Rainbow Babies and Children’s Hospital.
His research interests include the epidemiology of antibiotic resistant organisms in pediatric patient, and disaster preparedness for pediatric critical care. Dr. Toltzis has served on a number of local, regional and national medical committees focused on reducing infections in children and has been an invited lecturer at national and international infectious disease and critical care conferences.
Dr. Toltzis has published more than 60 papers in medical journals, edited a textbook on pediatric infectious diseases, contributed nearly 50 chapters to medical textbooks and made more than 50 abstract presentations at medical meetings. He is on the editorial board of Journal of Pediatrics.
He is a member of the Pediatric Infectious Disease Society, Society of Critical Care Medicine, American Academy of Pediatrics, Infectious Diseases Society of America and Society for Hospital Epidemiology of America.
Hospital acquired infections and antibiotic resistance in pediatrics
Disaster preparedness for pediatric critical care
- Nosocomial Infections
- Pediatric Critical Care Medicine - American Board of Pediatrics
- Pediatric Infectious Diseases - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Critical Care Medicine
Pediatric Critical Care Medicine - University Hospitals Of Cleveland (1992 - 1995)
Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Boston Children's Hospital (1982 - 1985)
Residency | Pediatrics/Chief Resident
Pediatrics/Chief Resident - University Hospitals Of Cleveland (1981 - 1982)
Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1979 - 1981)
Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1978 - 1979)
University Of Pennsylvania School Of Medicine (1978)
University Of Michigan (1974)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Philip Toltzis did not disclose any Outside Relationships with Industry.